Name | Mutated EGFR-IN-2 |
---|
Description | Mutated EGFR-IN-2 (compound 91) is a mutant-selective EGFR inhibitor extracted from patent WO2017036263A1, which potently inhibits single-mutant EGFR (T790M) and double-mutant EGFR (including L858R/T790M (IC50=<1nM) and ex19del/T790M), and can suppress activity of single gain-of-function mutant EGFR (including L858R and ex19del) as well. Mutated EGFR-IN-2 shows anti-tumor antivity[1]. |
---|---|
Related Catalog | |
Target |
EGFRT790M EGFRL858R EGFRex19del EGFR (L858R/T790M):<1 nM (IC50) EGFR (ex19del/T790M) |
References |
Molecular Formula | C29H35FN8O3 |
---|---|
Molecular Weight | 562.64 |